-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
-
Summary
-
Brainstorm Cell Therapeutics Inc. quarterly/annual Net Cash Provided by (Used in) Investing Activities history and growth rate from 2010 to 2023.
- Brainstorm Cell Therapeutics Inc. Net Cash Provided by (Used in) Investing Activities for the quarter ending December 31, 2023 was $196K, a 81.1% decline year-over-year.
- Brainstorm Cell Therapeutics Inc. Net Cash Provided by (Used in) Investing Activities for the twelve months ending December 31, 2023 was $2.19M, a 120% increase year-over-year.
- Brainstorm Cell Therapeutics Inc. annual Net Cash Provided by (Used in) Investing Activities for 2023 was $2.19M, a 120% increase from 2022.
- Brainstorm Cell Therapeutics Inc. annual Net Cash Provided by (Used in) Investing Activities for 2022 was $998K, a 209% increase from 2021.
- Brainstorm Cell Therapeutics Inc. annual Net Cash Provided by (Used in) Investing Activities for 2021 was $323K.
Net Cash Provided by (Used in) Investing Activities, Trailing 12 Months (USD)
Net Cash Provided by (Used in) Investing Activities, Annual (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Annual Growth (%)